translocations or amplifications in addition to the genomic alterations now present in the initial CLL, but absence the frequent mutations observed in primary DLBCL indicating they could correspond to a different Organic category.Deep, specific next-technology sequencing has disclosed that subclonal mutations (i.e., Those people existing in only a